TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.86
−2.11%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.90
From 52W high−32.85%
Volume122744.00
Market cap$21.53M
P/E (TTM)—
P/S (TTM)6.6x
Div yield—
Key dataOct 19, 2026
Open
$1.90
From 52W high
−32.85%
Volume
122744.00
Market cap
$21.53M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.5x
P/E (TTM)
—
RSI (14)
31.2
MomentumView details →
1D Return
−2.11%
YTD Return
+15.34%
SummaryUpdated Jun 1, 2026
TherapeuticsMD, Inc. (NASDAQ:TXMD) is a women's healthcare company founded in 2008 and headquartered in Boca Raton, Florida. The company went public in 2007 and specializes in developing and commercializing prescription pharmaceutical products specifically designed for women's health needs. After experiencing significant revenue growth in earlier years, the company has undergone substantial restructuring, including asset divestitures and debt reduction, and currently operates with a much smaller revenue base focused on its core women's health products.
Similar companies
Latest newsMore news →